US Growth Companies With High Insider Ownership To Watch

In This Article:

As U.S. stock futures point to a higher open, investors are keenly watching the market's response to Nvidia's earnings report, hoping for a break from the recent four-day slump in major indices. In this environment of heightened anticipation and economic uncertainty, growth companies with high insider ownership can offer unique insights into potential resilience and alignment of interests between company leaders and shareholders.

Top 10 Growth Companies With High Insider Ownership In The United States

Name

Insider Ownership

Earnings Growth

Atour Lifestyle Holdings (NasdaqGS:ATAT)

26%

25.6%

Super Micro Computer (NasdaqGS:SMCI)

14.4%

27.6%

On Holding (NYSE:ONON)

19.1%

29.8%

Kingstone Companies (NasdaqCM:KINS)

20.8%

24.9%

Astera Labs (NasdaqGS:ALAB)

16.1%

61.1%

BBB Foods (NYSE:TBBB)

16.5%

41.1%

Clene (NasdaqCM:CLNN)

20.7%

59.1%

Enovix (NasdaqGS:ENVX)

12.6%

56.0%

Credit Acceptance (NasdaqGS:CACC)

14.2%

33.6%

Upstart Holdings (NasdaqGS:UPST)

12.6%

100.7%

Click here to see the full list of 198 stocks from our Fast Growing US Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Gambling.com Group

Simply Wall St Growth Rating: ★★★★★☆

Overview: Gambling.com Group Limited is a performance marketing company serving the global online gambling industry, with a market cap of $505.49 million.

Operations: The company generates its revenue primarily through its Gambling Affiliation segment, which amounted to $124.40 million.

Insider Ownership: 33.6%

Earnings Growth Forecast: 21% p.a.

Gambling.com Group is positioned for substantial growth, with earnings projected to increase by 21% annually, outpacing the US market. The company's Return on Equity is forecasted to reach a very high 41.3% in three years. Despite trading at 74.6% below its estimated fair value, analysts expect a price rise of 33.2%. Recent guidance indicates expected revenue of $170 million to $174 million for 2025, highlighting strong growth potential despite slower revenue expansion compared to earnings.

NasdaqGM:GAMB Earnings and Revenue Growth as at Feb 2025
NasdaqGM:GAMB Earnings and Revenue Growth as at Feb 2025

Harrow

Simply Wall St Growth Rating: ★★★★★☆

Overview: Harrow, Inc. is an eyecare pharmaceutical company focused on discovering, developing, and commercializing ophthalmic pharmaceutical products, with a market cap of approximately $981.90 million.

Operations: Harrow's revenue primarily comes from the discovery, development, and commercialization of innovative ophthalmic therapies, amounting to $133.22 million.